Mutations in α-helical solvent-exposed sites of eglin c have long-range effects: Evidence from molecular dynamics simulations

Proteins: Structure, Function and Genetics

Volumn 63, Issue 2, 2006, Pages 356-372

  Fetrow, Jacquelyn S ^a   Knutson, Stacy T ^a   Edgell, Marshall Hall ^b  

^a WAKE FOREST UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; EGLIN C; GLUTAMIC ACID; PROTEINASE INHIBITOR;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; GENE MUTATION; MEASUREMENT; MODEL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN STABILITY; SIMULATION; THERMODYNAMICS;

COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; MODELS, MOLECULAR; MUTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS;

EID: 33645281415     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.20794     Document Type: Article

References (60)

1. O'Neil KT, DeGrado WF. A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science 1990;250:646-651.
2. Finkelstein AV, Badretdinov AY, Ptitsyn OB. Physical reasons for secondary structure stability: alpha-helices in short peptides. Proteins 1991;10:287-299.
3. Blaber M, Zhang XJ, Matthews BW. Structural basis of amino acid alpha helix propensity. Science 1993;260:1637-1640.
4. Luque I, Mayorga OL, Freire E. Structure-based thermodynamic scale of alpha-helix propensities in amino acids. Biochemistry 1996;35:13681-13688.
5. Munoz V, Serrano L. Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. Biopolymers 1997;41:495-509.
6. Hol WG, van Duijnen PT, Berendsen HJ. The alpha-helix dipole and the properties of proteins. Nature 1978;273:443-446.
7. Lyu PC, Liff MI, Marky LA, Kallenbach NR. Side chain contributions to the stability of alpha-helical structure in peptides. Science 1990;250:669-673.
8. Serrano L, Sancho J, Hirshberg M, Fersht AR. Alpha-helix stability in proteins. I. Empirical correlations concerning substitution of side-chains at the N and C-caps and the replacement of alanine by glycine or serine at solvent-exposed surfaces. J Mol Biol 1992;227:544-559.
9. Wada A. The alpha-helix as an electric macro-dipole. Adv Biophys 1976:1-63.
10. Presta LG, Rose GD. Helix signals in proteins. Science 1988;240:1632-1641.
11. Harper ET, Rose GD. Helix stop signals in proteins and peptides: the capping box. Biochemistry 1993;32:7605-7609.
12. Doig AJ, Baldwin RL. N- and C-capping preferences for all 20 amino acids in alpha-helical peptides. Protein Sci 1995;4:1325-1336.
13. Aurora R, Srinivasan R, Rose GD. Rules for a-helix termination by glycine. Science 1994;264:1126-1130.
14. Richardson JS, Richardson DC. Amino acid preferences for specific locations at the ends of α helices. Science 1988;240:1648-1652.
15. Yi F, Sims DA, Pielak GJ, Edgell MH. Testing hypotheses about determinants of protein structure with high-precision, high-throughput stability measurements and statistical modeling. Biochemistry 2003;42:7594-7603.
16. Ceruso MA, Grottesi A, Di Nola A. Dynamic effects of mutations within two loops of cytochrome c551 from Pseudomonas aeruginosa. Proteins 2003;50:222-229.
17. Rod TH, Radkiewicz JL, Brooks 3rd CL. Correlated motion and the effect of distal mutations in dihydrofolate reductase. Proc Natl Acad Sci USA 2003;100:6980-6985.
18. Ishida H, Jochi Y, Kidera A. Dynamic structure of subtilisin-eglin c complex studied by normal mode analysis. Proteins 1998;32:324-333.
19. Clarkson MW, Lee AL. Long-range dynamic effects of point mutations propagate through side chains in the serine protease inhibitor eglin c. Biochemistry 2004;43:12448-12458.
20. Matthews SJ, Jandu SK, Leatherbarrow RJ. 13C NMR study of the effects of mutation on the tryptophan dynamics in chymotrypsin inhibitor 2: correlations with structure and stability. Biochemistry 1993;32:657-662.
21. Seemuller U, Eulitz M, Fritz H, Strobl A. Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. Hoppe Seylers Z Physiol Chem 1980;361:1841-1846.
22. Day R, Daggett V. Sensitivity of the folding/unfolding transition state ensemble of chymotrypsin inhibitor 2 to changes in temperature and solvent. Protein Sci 2005;14:1242-1252.
23. Bennion BJ, Daggett V. Counteraction of urea-induced protein denaturation by trimethylamine N-oxide: a chemical chaperone at atomic resolution. Proc Natl Acad Sci USA 2004;101:6433-6438.
24. Mucsi Z, Gaspari Z, Orosz G, Perczel A. Structure-oriented rational design of chymotrypsin inhibitor models. Protein Eng 2003;16:673-681.
25. Daggett V. Molecular dynamics simulations of protein unfolding/folding. Methods Mol Biol 2001;168:215-247.
26. Kurt N, Haliloglu T. Conformational dynamics of subtilisin-chymotrypsin inhibitor 2 complex by coarse-grained simulations. J Biomol Struct Dyn 2001;18:713-731.
27. Kurt N, Haliloglu T. Conformational dynamics of chymotrypsin inhibitor 2 by coarse-grained simulations. Proteins 1999;37:454-464.
28. Li A, Daggett V. Investigation of the solution structure of chymotrypsin inhibitor 2 using molecular dynamics: comparison to x-ray crystallographic and NMR data. Protein Eng 1995;8:1117-1128.
29. Itzhaki LS, Neira JL, Ruiz-Sanz J, de Prat-Gay G, Fersht AR. Search for nucleation sites in smaller fragments of chymotrypsin inhibitor 2. J Mol Biol 1995;254:289-304.
30. Itzhaki LS, Neira JL, Fersht AR. Hydrogen exchange in chymotrypsin inhibitor 2 probed by denaturants and temperature. J Mol Biol 1997;270:89-98.
31. Ladurner AG, Itzhaki LS, Fersht AR. Strain in the folding nucleus of chymotrypsin inhibitor 2. Fold Des 1997;2:363-368.
32. Mohana-Borges R, Silva JL, Ruiz-Sanz J, de Prat-Gay G. Folding of a pressure-denatured model protein. Proc Natl Acad Sci USA 1999;96:7888-7893.
33. Hyberts SG, Goldberg MS, Havel TF, Wagner G. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci 1992;1:736-751.
34. Frigerio F, Coda A, Pugliese L, Lionetti C, Menegatti E, Amiconi G, Schnebli HP, Ascenzi P, Bolognesi M. Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 Å resolution. J Mol Biol 1992;225:107-123.
35. Bode W, Papamokos E, Musil D. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. Eur J Biochem 1987;166:673-692.
36. Dauter Z, Betzel C, Genov N, Pipon N, Wilson KS. Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-c. Acta Crystallogr B Biol Crystallogr 1991;47:707-730.
37. Gros P, Fujinaga M, Dijkstra BW, Kalk KH, Hol WG. Crystallographic refinement by incorporation of molecular dynamics: thermostable serine protease thermitase complexed with eglin c. Acta Crystallogr B Biol Crystallogr 1989;45:488-499.
38. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983;22:2577-2637.
39. Daggett V, Li A, Itzhaki LS, Otzen DE, Fersht AR. Structure of the transition state for folding of a protein derived from experiment and simulation. J Mol Biol 1996;257:430-440.
40. Li A, Daggett V. Identification and characterization of the unfolding transition state of chymotrypsin inhibitor 2 by molecular dynamics simulations. J Mol Biol 1996;257:412-429.
41. Day R, Bennion BJ, Ham S, Daggett V. Increasing temperature accelerates protein unfolding without changing the pathway of unfolding. J Mol Biol 2002;322:189-203.
42. De Jong D, Riley R, Alonso DO, Daggett V. Probing the energy landscape of protein folding/unfolding transition states. J Mol Biol 2002;319:229-242.
43. Kazmirski SL, Wong KB, Freund SM, Tan YJ, Fersht AR, Daggett V. Protein folding from a highly disordered denatured state: the folding pathway of chymotrypsin inhibitor 2 at atomic resolution. Proc Natl Acad Sci USA 2001;98:4349-4354.
44. Ferrara P, Apostolakis J, Caflisch A. Computer simulations of protein folding by targeted molecular dynamics. Proteins 2000;39:252-260.
45. Ladurner AG, Itzhaki LS, Daggett V, Fersht AR. Synergy between simulation and experiment in describing the energy landscape of protein folding. Proc Natl Acad Sci USA 1998;95:8473-8478.
46. Pan Y, Daggett V. Direct comparison of experimental and calculated folding free energies for hydrophobic deletion mutants of chymotrypsin inhibitor 2: free energy perturbation calculations using transition and denatured states from molecular dynamics simulations of unfolding. Biochemistry 2001;40:2723-2731.
47. Hu H, Clarkson MW, Hermans J, Lee AL. Increased rigidity of eglin c at acidic pH: evidence from NMR spin relaxation and MD simulations. Biochemistry 2003;42:13856-13868.
48. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus. M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comp Chem 1983;4:187-217.
49. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926-935.
50. MacKerell Jr. AD, Brooks B, Brooks III CL, Nilsson L, Roux B, Won Y, Karplus M. CHARMM: the energy function and its parameterization with an overview of the program. In: Schleyer PvR, Schreiner PR, Allinger NL, Clark T, Gasteiger J, Kollman P, III HFS, editors. The encyclopedia of computational chemistry, Volume 1. Chichester: Wiley; 1998. p 271-277.
51. Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 1977;23:327-341.
52. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys 1995;103:8577-8593.
53. Ichiye T, Karplus M. Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins 1991;11:205-217.
54. Radkiewicz JL, Brooks CL. I. Protein dynamics in enzymatic catalysis: exploration of dihydrofolate reductase. J Am Chem Soc 2000;122:225-231.
55. Peng JW, Wagner G. Frequency spectrum of NH bonds in eglin c from spectral density mapping at multiple fields. Biochemistry 1995;34:16733-16752.
56. Lee AL, Kinnear SA, Wand AJ. Redistribution and loss of side chain entropy upon formation of a calmodulin-peptide complex. Nat Struct Biol 2000;7:72-77.
57. Loh AP, Pawley N, Nicholson LK, Oswald RE. An increase in side chain entropy facilitates effector binding: NMR characterization of the side chain methyl group dynamics in Cdc42Hs. Biochemistry 2001;40:4590-4600.
58. Finerty Jr. PJ. Muhandiram R, Forman-Kay JD. Side-chain dynamics of the SAP SH2 domain correlate with a binding hot spot and a region with conformational plasticity. J Mol Biol 2002;322:605-620.
59. Fuentes EJ, Der CJ, Lee AL. Ligand-dependent dynamics and intramolecular signaling in a PDZ domain. J Mol Biol 2004;335:1105-1115.
60. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33-38.